Efficacy of low-activity, microbial phytase in improving the bioavailability of phosphorus in corn-soybean meal diets for pigs. 1995

G L Cromwell, and R D Coffey, and H J Monegue, and J H Randolph
Department of Animal Sciences, University of Kentucky, Lexington 40546, USA.

Two experiments involving 115 pigs were conducted to assess the efficacy of a microbial phytase (Allzyme Phytase; Alltech, Nicholasville, KY) produced by Aspergillus niger in low-P, corn-soybean meal-based diets. The phytase supplement contained 50 phytase units/g and 1.43% P. In Exp. 1, growing-finishing pigs were fed fortified corn-soybean meal diets formulated to be adequate (.50%) or inadequate (.30%) in P during the growing phase (38 to 57 kg BW) followed by adequate (.40%) or inadequate (.30%) P, respectively, during the finishing phase (to 101 kg BW). Dicalcium phosphate was the source of supplemental P. Half the diets were supplemented with phytase at 500 phytase units/kg. Rate and efficiency of gain and bone breaking strength were decreased (P < .01) when the low-P diet was fed. Adding phytase to the low-P diet restored performance and bone breaking strength (P < .01) to levels that approached those of pigs fed the adequate-P diet. In Exp. 2, growing pigs (13 kg BW), were fed a low-P (.32% total P; .048% available P) based diet supplemented with graded levels of monosodium phosphate to provide 0, .075, and .15% added P or with phytase to supply 250, 500, 1,000, or 2,000 phytase units/kg. Chromic oxide was included as an indigestible marker for determining apparent absorption and fecal excretion of P. Performance and bone strength increased linearly with added monosodium phosphate (P < .01) and with increasing levels of supplemental phytase (P < .05). A portion of these increases from phytase was attributed to the P supplied by the phytase mix (.007, .014, .028, .057%, respectively).(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008297 Male Males
D010832 6-Phytase An enzyme that catalyzes the conversion of myo-inositol hexakisphosphate and water to 1L-myo-inositol 1,2,3,4,5-pentakisphosphate and orthophosphate. EC 3.1.3.26. Phytase,6 Phytase
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D003313 Zea mays A plant species of the family POACEAE. It is a tall grass grown for its EDIBLE GRAIN, corn, used as food and animal FODDER. Corn,Indian Corn,Maize,Teosinte,Zea,Corn, Indian
D005260 Female Females
D005527 Food, Fortified Any food that has been supplemented with essential NUTRIENTS either in quantities that are greater than those normally present, or which are not found in the food typically. Fortified food also includes food enriched by adding various nutrients to compensate for those removed by refinement or processing. (Modified from Segen, Dictionary of Modern Medicine, 1992). Enriched Food,Food, Supplemented,Enriched Foods,Food, Enriched,Foods, Enriched,Foods, Fortified,Foods, Supplemented,Fortified Food,Fortified Foods,Supplemented Food,Supplemented Foods
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000821 Animal Feed Foodstuff used especially for domestic and laboratory animals, or livestock. Fodder,Animal Feeds,Feed, Animal,Feeds, Animal,Fodders
D001234 Aspergillus niger An imperfect fungus causing smut or black mold of several fruits and vegetables such as grapes, apricots, onions, and peanuts, and is a common contaminant of food. Aspergillus lacticoffeatus
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

G L Cromwell, and R D Coffey, and H J Monegue, and J H Randolph
January 2000, Journal of animal science,
G L Cromwell, and R D Coffey, and H J Monegue, and J H Randolph
December 1993, Journal of animal science,
G L Cromwell, and R D Coffey, and H J Monegue, and J H Randolph
May 1997, Journal of animal science,
G L Cromwell, and R D Coffey, and H J Monegue, and J H Randolph
December 1993, Journal of animal science,
G L Cromwell, and R D Coffey, and H J Monegue, and J H Randolph
January 1994, Journal of animal science,
G L Cromwell, and R D Coffey, and H J Monegue, and J H Randolph
December 1996, Journal of animal science,
G L Cromwell, and R D Coffey, and H J Monegue, and J H Randolph
November 1997, Poultry science,
G L Cromwell, and R D Coffey, and H J Monegue, and J H Randolph
October 1998, Journal of animal science,
Copied contents to your clipboard!